Cumulative health deficits, APOE genotype, and risk for later-life mild cognitive impairment and dementia

J Neurol Neurosurg Psychiatry. 2021 Feb;92(2):136-142. doi: 10.1136/jnnp-2020-324081. Epub 2020 Nov 13.

Abstract

Objective: To determine whether health-deficit accumulation is associated with the risks of mild cognitive impairment (MCI) and dementia independently of APOE genotype.

Methods: A frailty index was calculated using the deficit-accumulation approach in participants aged 50 years and older from the National Alzheimer's Coordinating Center. Cognitive status was determined by clinical evaluation. Using multistate transition models, we assessed the extent to which an increasing degree of frailty affected the probabilities of transitioning between not cognitively impaired (NCI), MCI, and dementia.

Results: Participants (n=14 490) had a mean age of 72.2 years (SD=8.9 years; range=50-103 years). Among those NCI at baseline (n=9773), each 0.1 increment increase in the frailty index was associated with a higher risk of developing MCI and a higher risk of progressing to dementia. Among those with MCI at baseline (n=4717), higher frailty was associated with a higher risk of progressing to dementia, a lower probability of being reclassified as NCI, and a higher likelihood of returning to MCI in those that were reclassified as NCI. These risk effects were present and similar in both carriers and non-carriers of the APOE ε4 allele.

Conclusion: Among older Americans, health-deficit accumulation affects the likelihood of progressive cognitive impairment and the likelihood of cognitive improvement independently of a strong genetic risk factor for dementia. Frailty represents an important risk factor for cognitive dysfunction and a marker of potential prognostic value.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alleles
  • Apolipoprotein E4 / genetics
  • Apolipoproteins E / genetics*
  • Cognitive Dysfunction / etiology*
  • Cognitive Dysfunction / genetics
  • Dementia / etiology*
  • Dementia / genetics
  • Female
  • Frailty / complications*
  • Genetic Predisposition to Disease / genetics*
  • Genotype
  • Geriatric Assessment
  • Humans
  • Male
  • Middle Aged
  • Risk Factors

Substances

  • Apolipoprotein E4
  • Apolipoproteins E

Grants and funding